Patents Assigned to Pacesetter, Inc.
  • Patent number: 11938330
    Abstract: A leadless cardiac pacemaker is provided which can include any number of features. In one embodiment, the pacemaker can include a tip electrode, pacing electronics disposed on a p-type substrate in an electronics housing, the pacing electronics being electrically connected to the tip electrode, an energy source disposed in a cell housing, the energy source comprising a negative terminal electrically connected to the cell housing and a positive terminal electrically connected to the pacing electronics, wherein the pacing electronics are configured to drive the tip electrode negative with respect to the cell housing during a stimulation pulse. The pacemaker advantageously allows p-type pacing electronics to drive a tip electrode negative with respect to the can electrode when the can electrode is directly connected to a negative terminal of the cell. Methods of use are also provided.
    Type: Grant
    Filed: July 6, 2020
    Date of Patent: March 26, 2024
    Assignee: Pacesetter, Inc.
    Inventors: Kenneth J. Carroll, Alan Ostroff, Peter M. Jacobson
  • Patent number: 11931587
    Abstract: A system is provided that includes a first electrode configured to be located within a septal wall, and a second electrode configured to be located outside of the septal wall. The system also includes an impedance circuit configured to measure impedance along an impedance monitoring (IM) vector between the first and second electrodes. One or more processors are also provided that are configured to obtain impedance data indicative of an impedance along the IM vector with the first electrode located at different depths within the septal wall, the impedance data including a set of data values associated with different depths of the first electrode within the septal wall. The one or more processors are also configured to determine when the first electrode is located at a target depth within the septal wall based on the impedance data.
    Type: Grant
    Filed: July 6, 2021
    Date of Patent: March 19, 2024
    Assignee: PACESETTER, INC.
    Inventors: Jan O. Mangual-Soto, Wenwen Li, Yun Qiao, Kyungmoo Ryu
  • Patent number: 11931590
    Abstract: Described herein are methods for use with an implantable system including at least an atrial leadless pacemaker (aLP). Also described herein are specific implementations of an aLP, as well as implantable systems including an aLP. In certain embodiments, the aLP senses a signal from which cardiac activity associated with a ventricular chamber can be detected by the aLP itself based on feature(s) of the sensed signal. The aLP monitors the sensed signal for an intrinsic or paced ventricular activation within a ventricular event monitor window. In response to the aLP detecting an intrinsic or paced ventricular activation itself from the sensed signal within the ventricular event monitor window, the aLP resets an atrial escape interval timer that is used by the aLP to time delivery of an atrial pacing pulse if an intrinsic atrial activation is not detected within an atrial escape interval.
    Type: Grant
    Filed: May 14, 2021
    Date of Patent: March 19, 2024
    Assignee: Pacesetter, Inc.
    Inventors: Xiaoyi Min, Weiqun Yang, Benjamin T. Persson, Nima Badie, Kyungmoo Ryu, Gabriel Mouchawar
  • Patent number: 11931568
    Abstract: A subcutaneous implantable medical device and method (SIMD) provided. A pulse generator (PG) is configured to be positioned subcutaneously within a lateral region of a chest of a patient. The PG has a housing that includes a PG electrode. The PG has an electronics module. An elongated lead is electrically coupled to the pulse generator. The elongated lead includes a first electrode that is configured to be positioned along a first parasternal region proximate a sternum of the patient and a second electrode that is configured to be positioned at an anterior region of the patient. The first and second electrodes are coupled to be electrically common with one another. The electronics module is configured to provide electrical shocks for antiarrhythmic therapy along at least one shocking vector between the PG electrode and the first and second electrodes.
    Type: Grant
    Filed: February 28, 2022
    Date of Patent: March 19, 2024
    Assignee: Pacesetter, Inc.
    Inventors: Xiaoyi Min, Kyungmoo Ryu, Keith Victorine, Stuart Rosenberg, Gene A. Bornzin
  • Patent number: 11935706
    Abstract: A capacitor has an anode with one or more active layers that each includes fused particles positioned on a current collector. The current collector includes tunnels that extend from a first face of the current collector to a second face of the current collector.
    Type: Grant
    Filed: August 4, 2022
    Date of Patent: March 19, 2024
    Assignee: Pacesetter, Inc.
    Inventor: Xiaofei Jiang
  • Publication number: 20240081734
    Abstract: Described herein are apparatuses and methods for classifying a patient as being asleep or awake. Such an apparatus can include an accelerometer and a processor. The accelerometer, alone or in combination with the processor, is used to determine an activity level of the patient and a posture of the patient. The processor is configured to classify the patient as being asleep in response to both (i) the posture of the patient being recumbent or reclined for at least a sleep latency duration, and (ii) the activity level of the patient not exceeding an activity threshold for at least the sleep latency duration; and classify the patient as being awake in response to at least one of (iii) the posture of the patient being upright for at least an awake latency duration, or (iv) the activity level of the patient exceeding the activity threshold for at least the awake latency duration.
    Type: Application
    Filed: November 14, 2023
    Publication date: March 14, 2024
    Applicant: Pacesetter, Inc.
    Inventors: Jong Gill, Prakrit Shrestha, Kyungmoo Ryu
  • Patent number: 11925811
    Abstract: Described herein are methods, devices, and systems for providing an implantable leadless pacemaker (LP) with a remote follow-up capability whereby the LP can provide diagnostic information to an external device that is incapable of programming the LP, wherein the LP includes two or more implantable electrodes used to output both pacing pulses and conductive communication pulses. Such a method can include the LP monitoring for a presence of one or more notification conditions associated with the LP and/or associated with a patient within which the LP is implanted, and the LP periodically outputting an advertisement sequence of pulses, using at least implantable electrodes of the LP, irrespective of whether the LP recognizes the presence of at least one notification condition. The method can also include the LP recognizing the presence of at least one notification condition, and based thereon, the LP also outputting a notification sequence of pulses.
    Type: Grant
    Filed: April 5, 2021
    Date of Patent: March 12, 2024
    Assignee: Pacesetter, Inc.
    Inventors: Matthew G. Fishler, Suresh Gurunathan, Benjamin T. Persson
  • Patent number: 11918817
    Abstract: Described herein are methods, devices, and systems for providing an implantable leadless pacemaker (LP) with a remote follow-up capability whereby the LP can provide diagnostic information to an external device that is incapable of programming the LP, wherein the LP includes two or more implantable electrodes used to output both pacing pulses and conductive communication pulses. Such a method can include the LP monitoring for a presence of one or more notification conditions associated with the LP and/or associated with a patient within which the LP is implanted, and the LP periodically outputting an advertisement sequence of pulses, using at least implantable electrodes of the LP, irrespective of whether the LP recognizes the presence of at least one notification condition. The method can also include the LP recognizing the presence of at least one notification condition, and based thereon, the LP also outputting a notification sequence of pulses.
    Type: Grant
    Filed: April 5, 2021
    Date of Patent: March 5, 2024
    Assignee: Pacesetter, Inc.
    Inventors: Matthew G. Fishler, Suresh Gurunathan, Benjamin T. Persson
  • Patent number: 11918820
    Abstract: A leadless biostimulator, such as a leadless cardiac pacemaker, having a header assembly that includes overmolded components, is described. The header assembly includes a helix mount overmolded on a flange of an electrical feedthrough assembly. A fixation element is mounted on the helix mount. The overmolded helix mount fills a recess in an outer surface of the flange to robustly join the header assembly components. The electrical feedthrough assembly includes an electrode contained within the flange to deliver electrical impulses to a target anatomy, and an insulator that separates the electrode from the flange. The overmolded helix mount can conform or adhere to the outer surfaces of the flange and the insulator to electrically isolate the electrode from the flange. Other embodiments are also described and claimed.
    Type: Grant
    Filed: January 20, 2021
    Date of Patent: March 5, 2024
    Assignee: PACESETTER, INC.
    Inventors: Brett C. Villavicencio, Gintare Kerezyte, Wesley Alleman, Kavous Sahabi
  • Publication number: 20240065637
    Abstract: A medical data and diagnostics management system for processing classified electrogram (EGM) datasets includes a server system that receives transmissions of classified EGM datasets, each corresponding to an arrhythmic episode detected by an implantable medical device (IMD), and applies a machine-learning model to each classified EGM dataset, thereby determining confidence indicator(s) relating to the IMD classification for each arrhythmic episode. Based upon the confidence indicator(s), the server system generates a set of machine-adjudicated EGM datasets, assigns a ranking score to each machine-adjudicated EGM dataset, and selects for display (for clinical analysis) a subset of the machine-adjudicated EGM datasets based upon their ranking scores. The machine-adjudicated EGM datasets are also stored in a database and further processed to generate diagnostic information and/or diagnostic alerts relating to the arrhythmic episodes detected by the IMD over time.
    Type: Application
    Filed: July 31, 2023
    Publication date: February 29, 2024
    Applicant: Pacesetter, Inc.
    Inventors: Aditya Goil, Kevin Davis, Elnaz Lashgari, Gabriel Mouchawar
  • Patent number: 11904162
    Abstract: A biostimulator, such as a leadless cardiac pacemaker, including a fixation element and an electrode mounted on a resilient scaffold, is described. The fixation element and the resilient scaffold are coupled to a housing of the biostimulator. The resilient scaffold can support the electrode against a target tissue at a location that is radially offset from a location where the fixation element anchors the housing to the target tissue. A flexibility of the resilient scaffold allows the electrode to conform to a shape and movement of the target tissue when the housing is rigidly fixed to the target tissue by the fixation element. The resiliently supported electrode that is radially offset from the anchor point can reliably pace the target tissue without piercing the target tissue. Other embodiments are also described and claimed.
    Type: Grant
    Filed: August 10, 2022
    Date of Patent: February 20, 2024
    Assignee: PACESETTER, INC.
    Inventors: Thomas B. Eby, Alex C. Soriano, Mark Carlson
  • Patent number: 11896831
    Abstract: Methods and devices for managing establishment of a communications link between an external instrument (EI) and an implantable medical device (IMD) are provided. The methods and devices comprise storing, in memory in at least one of the IMD or the EI an advertising schedule defining a pattern for advertisement notices. The advertisement notices are distributed un-evenly and separated by unequal advertisement intervals. The method transmits, from a transmitter in at least one of the IMD or the EI the advertisement notices. The advertisement notices are distributed as defined by the advertising schedule. The method establishes a communication session between the IMD and the EI.
    Type: Grant
    Filed: March 7, 2022
    Date of Patent: February 13, 2024
    Assignee: Pacesetter, Inc.
    Inventors: Yongjian Wu, Samir Shah, Heidi Hellman, Reza Shahandeh, Tejpal Singh, Youjing Huang, Chao-Wen Young
  • Patent number: 11901134
    Abstract: Fabricating a capacitor includes forming conduits in a porous layer of material. The porous layer of material has particles that each includes a dielectric on a core. The formation of the conduits causes a portion of the dielectric to convert from a first phase to a second phase. The method also includes removing at least a portion of the second phase of the dielectric from the porous layer of material.
    Type: Grant
    Filed: November 24, 2020
    Date of Patent: February 13, 2024
    Assignee: Pacesetter, Inc.
    Inventors: Ralph Jason Hemphill, David R. Bowen, Thomas F. Strange, Xiaofei Jiang
  • Patent number: 11896839
    Abstract: Disclosed herein are implantable medical devices and systems, and methods for used therewith, that selectively perform atrial overdrive pacing while an intrinsic atrial rate of a patient is within a specified range. Such a method can involve measuring intervals between a plurality of intrinsic atrial depolarizations that occur during a specified period, and classifying intrinsic atrial activity as stable or unstable based on the measured intervals. In response to classifying the intrinsic atrial activity as stable, atrial overdrive pacing is performed. In response to classifying the intrinsic atrial rate as unstable, atrial overdrive pacing is not performed (i.e., is abstained from being performed). Over time, effectiveness of performing atrial overdrive pacing using various different atrial interval shorting deltas are recorded in a log and updated, and the log is used to determine a preferred rate at which to perform atrial overdrive pacing for various different measured intervals.
    Type: Grant
    Filed: August 14, 2020
    Date of Patent: February 13, 2024
    Assignee: Pacesetter, Inc.
    Inventor: Xing Pei
  • Patent number: 11896387
    Abstract: Described herein are methods, devices, and systems that use electrogram (EGM) or electrocardiogram (ECG) data for sleep apnea detection. An apparatus and method detect potential apnea events (an apnea or hypopnea event) using a signal indicative of cardiac electrical activity of a patient's heart, such as an EGM or ECG. Variations in one or more morphological or temporal features of the signal over several cardiac cycles are determined and used to detect a potential apnea event in a measurement period. Checks can then be made for a number of factors which could result in a false detection of an apnea event and if such factors are not present, an apnea event is recorded. Described herein are also methods, devices, and systems for classifying a patient as being asleep or awake, which can be used to selectively enable and disable sleep apnea detection monitoring, as well as in other manners.
    Type: Grant
    Filed: April 20, 2021
    Date of Patent: February 13, 2024
    Assignee: Pacesetter, Inc.
    Inventors: Jong Gill, Prakrit Shrestha, Kyungmoo Ryu
  • Publication number: 20240042220
    Abstract: Methods, systems, and devices that detect arrhythmic episodes and perform arrhythmia discrimination are described. Such a system includes a leadless pacemaker (LP) that senses a near-field electrogram (NF-EGM), and a non-vascular implantable cardioverter defibrillator (NV-ICD) that senses a far-field electrogram (FF-EGM). The LP determines cardiac activity information based on the NF-EGM and optionally also based on paced cardiac events caused by the LP.
    Type: Application
    Filed: August 4, 2022
    Publication date: February 8, 2024
    Applicant: Pacesetter, Inc.
    Inventor: Matthew G. Fishler
  • Patent number: 11890115
    Abstract: Computer implemented methods, devices and systems for monitoring a trend in heart failure (HF) progression are provided. The method comprises sensing left ventricular (LV) activation events at multiple LV sensing sites along a multi-electrode LV lead. The activation events are generated in response to an intrinsic or paced ventricular event. The method implements program instructions on one or more processors for automatically determining a conduction pattern (CP) across the LV sensing sites based on the LV activation events, identifying morphologies (MP) for cardiac signals associated with the LV activation events and repeating the sensing, determining and identifying operations, at select intervals, to build a CP collection and an MP collection. The method calculates an HF trend based on the CP collection and MP collection and classifies a patient condition based on the HF trend to form an HF assessment.
    Type: Grant
    Filed: June 6, 2022
    Date of Patent: February 6, 2024
    Assignee: Pacesetter, Inc.
    Inventors: Nima Badie, Jan O. Mangual-Soto, Luke C. McSpadden, Louis-Philippe Richer, Jong Gill
  • Patent number: 11894199
    Abstract: A method of manufacturing an aluminum electrolytic capacitor includes impregnating an aluminum electrolytic capacitor with a first electrolyte to form a first impregnated capacitor, aging the first impregnated capacitor using a first aging process to form a first aged capacitor, impregnating the first aged capacitor with a second electrolyte to form a second impregnated capacitor, the second electrolyte being different from the first electrolyte, aging the second impregnated capacitor using a final aging process to form a final aged capacitor, and impregnating the final aged capacitor with a third electrolyte.
    Type: Grant
    Filed: June 10, 2021
    Date of Patent: February 6, 2024
    Assignee: Pacesetter, Inc.
    Inventors: Pete J. Fernstrom, Jason Hemphill, Timothy Marshall, Tommy T. Davis, Joseph Beauvais
  • Patent number: 11890032
    Abstract: A catheter system for retrieving a leadless cardiac pacemaker from a patient is provided. The cardiac pacemaker can include a docking or retrieval feature configured to be grasped by the catheter system. In some embodiments, the retrieval catheter can include a snare configured to engage the retrieval feature of the pacemaker. The retrieval catheter can include a torque shaft selectively connectable to a docking cap and be configured to apply rotational torque to a pacemaker to be retrieved. Methods of delivering the leadless cardiac pacemaker with the delivery system are also provided.
    Type: Grant
    Filed: June 22, 2022
    Date of Patent: February 6, 2024
    Assignee: PACESETTER, INC.
    Inventors: Alexander Khairkhahan, Alan Klenk, Thomas Blake Eby
  • Patent number: 11883672
    Abstract: Methods, systems, and devices that are used for improving cardiac resynchronization therapy (CRT) are described herein. Such a method can include, for each set of pacing parameters, of a plurality of sets of pacing parameters, performing CRT using a set of pacing parameters and simultaneously therewith sensing a plurality of intracardiac electrograms (IEGMs) using different combinations of implanted electrodes. Additionally, for each set of pacing parameters, of the plurality of sets of pacing parameters, the method includes producing a respective reconstructed multi-lead surface electrocardiogram (ECG) based on the plurality of IEGMs that were sensed while CRT was performed using the set of pacing parameters. The method also includes analyzing the reconstructed multi-lead surface ECGs that were produced for the plurality of sets of pacing parameters, and based on results thereof, identifying a set of pacing parameters to be use for further CRT.
    Type: Grant
    Filed: February 2, 2021
    Date of Patent: January 30, 2024
    Assignee: Pacesetter, Inc.
    Inventors: Donald L. Hopper, Luke C. McSpadden, Louis-Philippe Richer, Jan Mangual, Nima Badie, Chunlan Jiang